US Patent 7652144 Compounds as PDE IV and TNF inhibitors

Patent 7652144 was granted and assigned to Aventis Pharma on January, 2010 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

January 26, 2010

Patent Application Number

11764317

Date Filed

June 18, 2007

Patent Primary Examiner

Patent abstract

A compound of formula XIX

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7652144 Compounds as PDE IV and TNF inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.